JP2011513410A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513410A5
JP2011513410A5 JP2010549729A JP2010549729A JP2011513410A5 JP 2011513410 A5 JP2011513410 A5 JP 2011513410A5 JP 2010549729 A JP2010549729 A JP 2010549729A JP 2010549729 A JP2010549729 A JP 2010549729A JP 2011513410 A5 JP2011513410 A5 JP 2011513410A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
aryl
independently
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010549729A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513410A (ja
JP5586484B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/035111 external-priority patent/WO2009111239A2/en
Publication of JP2011513410A publication Critical patent/JP2011513410A/ja
Publication of JP2011513410A5 publication Critical patent/JP2011513410A5/ja
Application granted granted Critical
Publication of JP5586484B2 publication Critical patent/JP5586484B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010549729A 2008-03-05 2009-02-25 ピロリジン誘導体 Active JP5586484B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3387708P 2008-03-05 2008-03-05
US61/033,877 2008-03-05
PCT/US2009/035111 WO2009111239A2 (en) 2008-03-05 2009-02-25 Pyrrolidine derivatives

Publications (3)

Publication Number Publication Date
JP2011513410A JP2011513410A (ja) 2011-04-28
JP2011513410A5 true JP2011513410A5 (US07846941-20101207-C00217.png) 2012-04-12
JP5586484B2 JP5586484B2 (ja) 2014-09-10

Family

ID=41054296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549729A Active JP5586484B2 (ja) 2008-03-05 2009-02-25 ピロリジン誘導体

Country Status (16)

Country Link
US (1) US8022096B2 (US07846941-20101207-C00217.png)
EP (1) EP2252582B1 (US07846941-20101207-C00217.png)
JP (1) JP5586484B2 (US07846941-20101207-C00217.png)
KR (1) KR101634656B1 (US07846941-20101207-C00217.png)
CN (1) CN101970402B (US07846941-20101207-C00217.png)
AU (1) AU2009222198B2 (US07846941-20101207-C00217.png)
BR (1) BRPI0906094B8 (US07846941-20101207-C00217.png)
CA (1) CA2717518C (US07846941-20101207-C00217.png)
ES (1) ES2515194T3 (US07846941-20101207-C00217.png)
HK (1) HK1149261A1 (US07846941-20101207-C00217.png)
MY (1) MY155630A (US07846941-20101207-C00217.png)
NZ (1) NZ587911A (US07846941-20101207-C00217.png)
RU (1) RU2494094C2 (US07846941-20101207-C00217.png)
TW (1) TWI385163B (US07846941-20101207-C00217.png)
WO (1) WO2009111239A2 (US07846941-20101207-C00217.png)
ZA (1) ZA201006329B (US07846941-20101207-C00217.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2911655A1 (en) 2012-10-24 2015-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Tpl2 kinase inhibitors for preventing or treating diabetes and for promoting -cell survival
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
CN104447479B (zh) * 2015-01-13 2016-03-23 佛山市赛维斯医药科技有限公司 含金刚烷和酰胺类衍生物、其制备方法和用途
CN104478778B (zh) * 2015-01-13 2016-03-16 佛山市赛维斯医药科技有限公司 金刚烷酰胺类衍生物、其制备方法和用途
CN104496877B (zh) * 2015-01-13 2016-06-01 佛山市赛维斯医药科技有限公司 一种腈基金刚烷酰胺衍生物、其制备方法和用途
CN104529855B (zh) * 2015-01-13 2016-04-13 佛山市赛维斯医药科技有限公司 一种含羟基金刚烷和酰胺结构的衍生物、其制备方法和用途
CN104447478B (zh) * 2015-01-13 2016-04-13 佛山市赛维斯医药科技有限公司 一种含腈基金刚烷和酰胺结构的衍生物、其制备方法和用途
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
CN114641277B (zh) * 2019-12-31 2023-06-13 石药集团中奇制药技术(石家庄)有限公司 一种二肽基肽酶4抑制剂的药物组合物及其制备方法和应用
WO2021136491A1 (zh) * 2019-12-31 2021-07-08 石药集团中奇制药技术(石家庄)有限公司 一种二肽基肽酶iv抑制剂的晶型及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490807B1 (ko) * 1995-11-28 2005-10-14 세파론, 인코포레이티드 시스테인및세린프로테아제의d-아미노산함유억제제
JP2000264882A (ja) * 1999-03-18 2000-09-26 Nippon Shokubai Co Ltd 有機アミド化合物およびその製造方法
GB9928330D0 (en) * 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
TWI243162B (en) 2000-11-10 2005-11-11 Taisho Pharmaceutical Co Ltd Cyanopyrrolidine derivatives
US6861440B2 (en) 2001-10-26 2005-03-01 Hoffmann-La Roche Inc. DPP IV inhibitors
CN100430386C (zh) * 2002-11-07 2008-11-05 默克公司 苯丙氨酸衍生物作为二肽基肽酶抑制剂用于治疗或预防糖尿病
ES2278213T3 (es) * 2002-11-07 2007-08-01 MERCK & CO., INC. Derivados de fenilamina como inhibidores de la dipeptidilpeptidasa en el tratamiento o la prevencion de la diabetes.
JP2004203526A (ja) 2002-12-24 2004-07-22 Sharp Corp 記録装置
US7345180B2 (en) 2003-01-31 2008-03-18 Sanwa Kagaku Kenkyusho Co., Ltd. Compound inhibiting dipeptidyl peptidase IV
US7638638B2 (en) 2003-05-14 2009-12-29 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20070093492A1 (en) * 2004-03-09 2007-04-26 Weir-Torn Jiaang Pyrrolidine derivatives
AU2005221678B2 (en) * 2004-03-09 2008-10-09 National Health Research Institutes Pyrrolidine compounds
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors

Similar Documents

Publication Publication Date Title
JP2011513410A5 (US07846941-20101207-C00217.png)
JP2012092103A5 (US07846941-20101207-C00217.png)
JP2010511721A5 (US07846941-20101207-C00217.png)
JP2014521688A5 (US07846941-20101207-C00217.png)
JP2009533410A5 (US07846941-20101207-C00217.png)
JP2016506962A5 (US07846941-20101207-C00217.png)
JP2011500550A5 (US07846941-20101207-C00217.png)
JP2013537203A5 (US07846941-20101207-C00217.png)
JP2012515776A5 (US07846941-20101207-C00217.png)
JP2017537949A5 (US07846941-20101207-C00217.png)
JP2012513409A5 (US07846941-20101207-C00217.png)
JP2009515988A5 (US07846941-20101207-C00217.png)
JP2012513410A5 (US07846941-20101207-C00217.png)
JP2009536620A5 (US07846941-20101207-C00217.png)
JP2011518833A5 (US07846941-20101207-C00217.png)
JP2012508252A5 (US07846941-20101207-C00217.png)
JP2013536188A5 (US07846941-20101207-C00217.png)
JP2017538773A5 (US07846941-20101207-C00217.png)
JP2016540742A5 (US07846941-20101207-C00217.png)
JP2016040288A5 (US07846941-20101207-C00217.png)
JP2014518543A5 (US07846941-20101207-C00217.png)
JP2017517538A5 (US07846941-20101207-C00217.png)
JP2017526677A5 (US07846941-20101207-C00217.png)
JP2016531126A5 (US07846941-20101207-C00217.png)
JP2014500265A5 (US07846941-20101207-C00217.png)